NCT01050452已完成不适用
Gaps in Helminth Control: Safety and Efficacy of Drug Combinations. Study on Trichuris Trichiura.
DBL -Institute for Health Research and Development1 个研究点 分布在 1 个国家目标入组 750 人开始时间: 2007年10月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 750
- 试验地点
- 1
- 主要终点
- Record adverse reactions
研究概览
简要总结
This randomised, controlled, double-blinded clinical study investigates the safety and efficacy of albendazole (ALB), mebendazole (MBD) and ivermectin (IVM) separately, and ALB and MBD each in combination with IVM in the treatment of Trichuris trichiura in children aged 5-14 years.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 5 Years 至 15 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Those who are enrolled in class one to six
- •Are infected with T. trichiura
- •Whose parent consent and who are willing to participate
排除标准
- •Those with acute and chronic diseases other than T. trichiura
- •Those with a history of any serious adverse drug reactions
研究组 & 干预措施
1
Placebo Comparator
albendazole treatment
干预措施: albendazole (Drug)
2
Active Comparator
mebendazole treatment
干预措施: mebendazole (Drug)
3
Active Comparator
ivermectin treatment
干预措施: ivermectin (Drug)
4
Active Comparator
albendazole + ivermectin treatment
干预措施: albendazole + ivermectin (Drug)
5
Active Comparator
mebendazole + ivermectin treatment
干预措施: mebendazole + ivermectin (Drug)
结局指标
主要结局
Record adverse reactions
时间窗: 6 weeks
次要结局
- Efficacy of treatment(6 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Safety and Efficacy of Drug Combinations Against SchistosomiasisParasitic DiseasesNCT01050374DBL -Institute for Health Research and Development650
已完成
不适用
Safety and Efficacy of Drug Combinations Against Triple InfectionsParasitic DiseasesNCT01050517DBL -Institute for Health Research and Development250
已完成
不适用
A Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head LiceHead LiceNCT01803581Oystershell NV60
已完成
2 期
Cholinergic Urticaria - Efficacy of DupilumabCholinergic UrticariaNCT03749148Charite University, Berlin, Germany48
已完成
2 期
Dupilumab in Chronic Spontaneous UrticariaChronic Spontaneous UrticariaRecurrent AngioedemaNCT03749135Charite University, Berlin, Germany72